NMRD

Nemaura Medical (NMRD)

About Nemaura Medical (NMRD)

Nemaura Medical, Inc. operates as a holding company. The firm engages in the provision of medical device research. It manufactures and commercializes glucose monitoring system, named sugarBEAT. The sugarBEAT consists of a disposable adhesive skin-patch connected to a rechargeable wireless transmitter that displays glucose readings at regular five minute intervals with the use of a mobile app. The company was founded by Dewan Fazlul Hoque Chowdhury on December 24, 2013 and is headquartered in New York, NY.

Details

Daily high
$0.02
Daily low
$0.02
Price at open
$0.02
52 Week High
$0.39
52 Week Low
$0.02
Market cap
714,200
Dividend yield
0.00%
Volume
211
Avg. volume
6,644
P/E ratio
-.05

Nemaura Medical News

Details

Daily high
$0.02
Daily low
$0.02
Price at open
$0.02
52 Week High
$0.39
52 Week Low
$0.02
Market cap
714,200
Dividend yield
0.00%
Volume
211
Avg. volume
6,644
P/E ratio
-.05